Post-needling soreness in an active myofascial trigger point (MTrP) of the upper trapezius muscle high-intensity laser therapy post-needling soreness dry needling pain myofascial trigger point
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged between 20 and 60 years old who agreed to participate in the study, received dry needling at the upper trapezius muscle on one side, and had post-needling soreness, for which VAS was evaluated more than 40 mm.
Exclusion criteria
Exclusion criteria: (1) Presence of a contraindication for HILT, such as malignancy, receiving radiotherapy in the past 6 months, bleeding in neck and shoulder areas; (2) History of underlying conditions which affect neck pain, such as fibromyalgia, cervical disc herniation, cervical spinal stenosis, cervical radiculopathy, cervical myelopathy, a history of neck surgery or trauma during the previous 6 months, shoulder joint pathology; (3) Use of analgesic medication or nonsteroidal anti-inflammatory drugs (NSAIDs) 24 hours prior to treatment; (4) Prior treatment with HILT; (5) Poor perception or communication; (6) Failure to commit to the 7-day follow-up appointment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post-needling soreness at the upper trapezius muscle immediate after laser therapy 100-mm visual analogue scale | — |
Secondary
| Measure | Time frame |
|---|---|
| time until resolution of post-needling soreness 7 days after the intervention 7-day pain diary,use of pain control strategies 7 days after the intervention 7-day pain diary | — |
Countries
Thailand
Contacts
Phramongkutklao hospital